
The scientist told Russia 1 channel that if the 'Light option' is used, Sputnik V vaccine's first component, without the second dose, 'it is possible to reduce the disease by 50 percent, or even 60 percent,' he said.
On March 29, the Ministry of Health of the Russian Federation registered the Sputnik Light drug against Covid-19 and, previously, on Feb.27, started immunization of those who took part in the study of the vaccine in Moscow.
Earlier, Gintsburg had declared that this vaccine will allow for the reduction of serious and fatal cases caused by the disease, but in no way we can say that it will replace Sputnik V.
The head of the team that produced Sputnik Light explained that the drug protects people during four to five months and aims at eliminating Sputnik V's main problem: the presence of two components administered to a patient with a time span of 21 days.
mh/aph/jha/mml
"light" - Google News
April 04, 2021 at 09:16PM
https://ift.tt/31KVQCt
10:02 Gamaleya director claims Sputnik Light reduces contagion - Prensa Latina
"light" - Google News
https://ift.tt/2Wm8QLw
https://ift.tt/2Stbv5k
Bagikan Berita Ini
0 Response to "10:02 Gamaleya director claims Sputnik Light reduces contagion - Prensa Latina"
Post a Comment